+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Human Liver Models Market 2024-2028

  • PDF Icon

    Report

  • 133 Pages
  • September 2024
  • Region: Global
  • TechNavio
  • ID: 5553840
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The human liver models market is forecasted to grow by USD 1.91 billion during 2021-2026, accelerating at a CAGR of 12.94% during the forecast period. The report on the human liver models market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of liver diseases, new drug approvals, and advancements in diagnostic methods.

The human liver models market is segmented as below:

By Type

  • Liver organoids
  • Liver-on-a-chip
  • 2D models
  • 3D bioprinting

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • Middle East and Africa
  • South America
This study identifies the technological advancements in the human organ model as one of the prime reasons driving the human liver models market growth during the next few years. Also, increase in collaborations for liver cancer drug development and robust R&D activities will lead to sizable demand in the market.

The report on the human liver models market covers the following areas:

  • Human liver models market sizing
  • Human liver models market forecast
  • Human liver models market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human liver models market vendors that include BioIVT LLC, CELLINK AB, CN Bio Innovations Ltd., Corning Inc., Cyfuse Biomedical K.K., Emulate Inc., H. L. Scientific, Hangzhou Jienuofei Biotechnology Co. Ltd., InSphero AG, Kirkstall Ltd., LifeSpan BioSciences Inc., MIMETAS BV, N. C. KANSIL and SONS, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and Western Surgical. Also, the human liver models market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
2.2 Market characteristics
  • Market characteristics analysis
2.3 Value chain analysis
  • Value Chain Analysis
3 Market Sizing
3.1 Market definition
  • Offerings of companies included in the market definition
3.2 Market segment analysis
  • Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Human Liver Models Market 2018 - 2022
  • Historic Market Size - Data Table on Global Human Liver Models Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
6.3 Liver organoids - Market size and forecast 2023-2028
  • Chart on Liver organoids - Market size and forecast 2023-2028 ($ million)
  • Data Table on Liver organoids - Market size and forecast 2023-2028 ($ million)
  • Chart on Liver organoids - Year-over-year growth 2023-2028 (%)
  • Data Table on Liver organoids - Year-over-year growth 2023-2028 (%)
6.4 Liver-on-a-chip - Market size and forecast 2023-2028
  • Chart on Liver-on-a-chip - Market size and forecast 2023-2028 ($ million)
  • Data Table on Liver-on-a-chip - Market size and forecast 2023-2028 ($ million)
  • Chart on Liver-on-a-chip - Year-over-year growth 2023-2028 (%)
  • Data Table on Liver-on-a-chip - Year-over-year growth 2023-2028 (%)
  • 2D models - Market size and forecast 2023-2028
  • Chart on 2D models - Market size and forecast 2023-2028 ($ million)
  • Data Table on 2D models - Market size and forecast 2023-2028 ($ million)
  • Chart on 2D models - Year-over-year growth 2023-2028 (%)
  • Data Table on 2D models - Year-over-year growth 2023-2028 (%)
  • 3D bioprinting - Market size and forecast 2023-2028
  • Chart on 3D bioprinting - Market size and forecast 2023-2028 ($ million)
  • Data Table on 3D bioprinting - Market size and forecast 2023-2028 ($ million)
  • Chart on 3D bioprinting - Year-over-year growth 2023-2028 (%)
  • Data Table on 3D bioprinting - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)
7 Customer Landscape
7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 APAC - Market size and forecast 2023-2028
  • Chart on APAC - Market size and forecast 2023-2028 ($ million)
  • Data Table on APAC - Market size and forecast 2023-2028 ($ million)
  • Chart on APAC - Year-over-year growth 2023-2028 (%)
  • Data Table on APAC - Year-over-year growth 2023-2028 (%)
8.6 Middle East and Africa - Market size and forecast 2023-2028
  • Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ million)
  • Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ million)
  • Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
  • Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
8.7 South America - Market size and forecast 2023-2028
  • Chart on South America - Market size and forecast 2023-2028 ($ million)
  • Data Table on South America - Market size and forecast 2023-2028 ($ million)
  • Chart on South America - Year-over-year growth 2023-2028 (%)
  • Data Table on South America - Year-over-year growth 2023-2028 (%)
8.8 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
8.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
8.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
8.12 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.13 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
  • Overview on factors of disruption
10.4 Industry risks
  • Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
  • Companies covered
11.2 Market positioning of companies
  • Matrix on companies position and classification
11.3 BioIVT LLC
  • BioIVT LLC - Overview
  • BioIVT LLC - Product / Service
  • BioIVT LLC - Key news
  • BioIVT LLC - Key offerings
11.4 CELLINK AB
  • CELLINK AB - Overview
  • CELLINK AB - Business segments
  • CELLINK AB - Key offerings
  • CELLINK AB - Segment focus
11.5 CN Bio Innovations Ltd.
  • CN Bio Innovations Ltd. - Overview
  • CN Bio Innovations Ltd. - Product / Service
  • CN Bio Innovations Ltd. - Key offerings
11.6 Corning Inc.
  • Corning Inc. - Overview
  • Corning Inc. - Business segments
  • Corning Inc. - Key news
  • Corning Inc. - Key offerings
  • Corning Inc. - Segment focus
11.7 Cyfuse Biomedical K.K.
  • Cyfuse Biomedical K.K. - Overview
  • Cyfuse Biomedical K.K. - Product / Service
  • Cyfuse Biomedical K.K. - Key offerings
11.8 Emulate Inc.
  • Emulate Inc. - Overview
  • Emulate Inc. - Product / Service
  • Emulate Inc. - Key offerings
11.9 Hangzhou Jienuofei Biotechnology Co. Ltd.
  • Hangzhou Jienuofei Biotechnology Co. Ltd. - Overview
  • Hangzhou Jienuofei Biotechnology Co. Ltd. - Product / Service
  • Hangzhou Jienuofei Biotechnology Co. Ltd. - Key offerings
11.10 InSphero AG
  • InSphero AG - Overview
  • InSphero AG - Product / Service
  • InSphero AG - Key offerings
11.11 MIMETAS BV
  • MIMETAS BV - Overview
  • MIMETAS BV - Product / Service
  • MIMETAS BV - Key offerings
11.12 Organovo Holdings Inc.
  • Organovo Holdings Inc. - Overview
  • Organovo Holdings Inc. - Business segments
  • Organovo Holdings Inc. - Key offerings
  • Organovo Holdings Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
12.4 Research methodology
  • Research methodology
12.5 Data procurement
  • Information sources
12.6 Data validation
  • Data validation
12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
12.8 Data synthesis
  • Data synthesis
12.9 360 degree market analysis
  • 360 degree market analysis
12.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Human Liver Models Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Liver organoids - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Liver organoids - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Liver organoids - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Liver organoids - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Liver-on-a-chip - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Liver-on-a-chip - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Liver-on-a-chip - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Liver-on-a-chip - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on 2D models - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on 2D models - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on 2D models - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on 2D models - Year-over-year growth 2023-2028 (%)
Exhibits 46: Chart on 3D bioprinting - Market size and forecast 2023-2028 ($ million)
Exhibits 47: Data Table on 3D bioprinting - Market size and forecast 2023-2028 ($ million)
Exhibits 48: Chart on 3D bioprinting - Year-over-year growth 2023-2028 (%)
Exhibits 49: Data Table on 3D bioprinting - Year-over-year growth 2023-2028 (%)
Exhibits 50: Market opportunity by Type ($ million)
Exhibits 51: Data Table on Market opportunity by Type ($ million)
Exhibits 52: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 53: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 54: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 55: Chart on Geographic comparison
Exhibits 56: Data Table on Geographic comparison
Exhibits 57: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on APAC - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on APAC - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on APAC - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on APAC - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on South America - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on South America - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on South America - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on South America - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 97: Market opportunity By Geographical Landscape ($ million)
Exhibits 98: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 99: Impact of drivers and challenges in 2023 and 2028
Exhibits 100: Overview on criticality of inputs and factors of differentiation
Exhibits 101: Overview on factors of disruption
Exhibits 102: Impact of key risks on business
Exhibits 103: Companies covered
Exhibits 104: Matrix on companies position and classification
Exhibits 105: BioIVT LLC - Overview
Exhibits 106: BioIVT LLC - Product / Service
Exhibits 107: BioIVT LLC - Key news
Exhibits 108: BioIVT LLC - Key offerings
Exhibits 109: CELLINK AB - Overview
Exhibits 110: CELLINK AB - Business segments
Exhibits 111: CELLINK AB - Key offerings
Exhibits 112: CELLINK AB - Segment focus
Exhibits 113: CN Bio Innovations Ltd. - Overview
Exhibits 114: CN Bio Innovations Ltd. - Product / Service
Exhibits 115: CN Bio Innovations Ltd. - Key offerings
Exhibits 116: Corning Inc. - Overview
Exhibits 117: Corning Inc. - Business segments
Exhibits 118: Corning Inc. - Key news
Exhibits 119: Corning Inc. - Key offerings
Exhibits 120: Corning Inc. - Segment focus
Exhibits 121: Cyfuse Biomedical K.K. - Overview
Exhibits 122: Cyfuse Biomedical K.K. - Product / Service
Exhibits 123: Cyfuse Biomedical K.K. - Key offerings
Exhibits 124: Emulate Inc. - Overview
Exhibits 125: Emulate Inc. - Product / Service
Exhibits 126: Emulate Inc. - Key offerings
Exhibits 127: Hangzhou Jienuofei Biotechnology Co. Ltd. - Overview
Exhibits 128: Hangzhou Jienuofei Biotechnology Co. Ltd. - Product / Service
Exhibits 129: Hangzhou Jienuofei Biotechnology Co. Ltd. - Key offerings
Exhibits 130: InSphero AG - Overview
Exhibits 131: InSphero AG - Product / Service
Exhibits 132: InSphero AG - Key offerings
Exhibits 133: MIMETAS BV - Overview
Exhibits 134: MIMETAS BV - Product / Service
Exhibits 135: MIMETAS BV - Key offerings
Exhibits 136: Organovo Holdings Inc. - Overview
Exhibits 137: Organovo Holdings Inc. - Business segments
Exhibits 138: Organovo Holdings Inc. - Key offerings
Exhibits 139: Organovo Holdings Inc. - Segment focus
Exhibits 140: Inclusions checklist
Exhibits 141: Exclusions checklist
Exhibits 142: Currency conversion rates for US$
Exhibits 143: Research methodology
Exhibits 144: Information sources
Exhibits 145: Data validation
Exhibits 146: Validation techniques employed for market sizing
Exhibits 147: Data synthesis
Exhibits 148: 360 degree market analysis
Exhibits 149: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global human liver models market: BioIVT LLC, CELLINK AB, CN Bio Innovations Ltd., Corning Inc., Cyfuse Biomedical K.K., Emulate Inc., H. L. Scientific, Hangzhou Jienuofei Biotechnology Co. Ltd., InSphero AG, Kirkstall Ltd., LifeSpan BioSciences Inc., MIMETAS BV, N. C. KANSIL and SONS, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and Western Surgical.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advancements in the human organ model."

According to the report, one of the major drivers for this market is the increasing prevalence of liver diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BioIVT LLC
  • CELLINK AB
  • CN Bio Innovations Ltd.
  • Corning Inc.
  • Cyfuse Biomedical K.K.
  • Emulate Inc.
  • H. L. Scientific
  • Hangzhou Jienuofei Biotechnology Co. Ltd.
  • InSphero AG
  • Kirkstall Ltd.
  • LifeSpan BioSciences Inc.
  • MIMETAS BV
  • N. C. KANSIL and SONS
  • Organovo Holdings Inc.
  • Pandorum Technologies Pvt. Ltd.
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • Western Surgical